A Multicenter, Open-label, RebiSmart™ Autoinjector Ease of Use Study (Q63835155)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Multicenter, Open-label, RebiSmart™ Autoinjector Ease of Use Study |
clinical trial |
Statements
Performs (English)
0 references
A Twelve-week, Phase IIIb, Open-label, Single-arm, Multicenter Trial to Evaluate Ease of Use of an Electronic Autoinjector (RebiSmart™) for Self-injection in Subjects With Relapsing Multiple Sclerosis (RMS) Treated With Rebif® 44mcg Subcutaneously (sc) Three Times a Week (Tiw) (English)
0 references
January 2010
0 references
August 2010
0 references
103
0 references
18 year
0 references
65 year
0 references